Literature DB >> 3500261

Regulation of cytolytic cell populations from human peripheral blood by B cell stimulatory factor 1 (interleukin 4).

M B Widmer1, R B Acres, H M Sassenfeld, K H Grabstein.   

Abstract

The effects of B cell stimulatory factor 1 (BSF-1) on the generation of human CTL and lymphokine-activated killer (LAK) cells in vitro were investigated. Both L-2 and BSF-1 were potent helper factors for the generation of antigen-specific CTL in MLC; detection of optimal BSF-1-induced CTL activity in this system occurred when BSF-1 was added to cultures after an initial period of activation during which exogenous BSF-1 was not present. In contrast to IL-2, BSF-1 failed to induce an LAK cell population, as detected with Daudi tumor targets, in cultures that had not been allosensitized. Furthermore, when both lymphokines were added together at culture initiation, BSF-1 inhibited the IL-2-driven generation of cytolytic cells. The differential ability of BSF-1 to promote the generation of CTL but not LAK could have important implications for lymphokine-mediated immunotherapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500261      PMCID: PMC2189660          DOI: 10.1084/jem.166.5.1447

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

2.  A differentiation factor required for the expression of cytotoxic T-cell function.

Authors:  D H Raulet; M J Bevan
Journal:  Nature       Date:  1982-04-22       Impact factor: 49.962

3.  Regulation of murine T cell proliferation by B cell stimulatory factor-1.

Authors:  K H Grabstein; L S Park; P J Morrissey; H Sassenfeld; V Price; D L Urdal; M B Widmer
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

4.  Identification of cellular mechanisms operational in vivo during the regression of established pulmonary metastases by the systemic administration of high-dose recombinant interleukin 2.

Authors:  J J Mulé; J C Yang; R L Afreniere; S Y Shu; S A Rosenberg
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

5.  Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2.

Authors:  J H Finke; J Scott; S Gillis; M L Hilfiker
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

6.  In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.

Authors:  I Yron; T A Wood; P J Spiess; S A Rosenberg
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

7.  Characterization of helper factors distinct from interleukin 2 necessary for the generation of allospecific cytolytic T lymphocytes.

Authors:  R D Garman; D P Fan
Journal:  J Immunol       Date:  1983-02       Impact factor: 5.422

8.  Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor.

Authors:  A Muraguchi; J L Butler; J H Kehrl; A S Fauci
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

9.  Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses.

Authors:  H Wagner; C Hardt; B T Rouse; M Röllinghoff; P Scheurich; K Pfizenmaier
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

10.  Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Authors:  E A Grimm; A Mazumder; H Z Zhang; S A Rosenberg
Journal:  J Exp Med       Date:  1982-06-01       Impact factor: 14.307

View more
  38 in total

1.  Modification of the Sendai virus-specific antibody and CD8+ T-cell responses in mice homozygous for disruption of the interleukin-4 gene.

Authors:  X Y Mo; M Y Sangster; R A Tripp; P C Doherty
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Antigen organization regulates cluster formation and induction of cytotoxic T lymphocytes by helper T cell subsets.

Authors:  G Stuhler; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

3.  Partial correction of defective generation of lymphokine-activated killer cells in patients with chronic myelogenous leukaemia after in vivo treatment with interferon-alpha (Wellferon).

Authors:  G Pawelec; E Schneider; G Ehninger; A Rehbein; H Schmidt
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Heterogeneous lymphokine-activated killer cell precursor populations. Development of a monoclonal antibody that separates two populations of precursors with distinct culture requirements and separate target-recognition repertoires.

Authors:  B A Fox; S A Rosenberg
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Amplification of altered self-reactive cytolytic T lymphocyte responses by cloned, allospecific human Th cells.

Authors:  S M Friedman; A Green; C Russo; D N Posnett; D Diffley; M K Crow
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

6.  Endogenously secreted IL-4 is required for mouse thymocytes to become cytotoxic. Human, but not mouse, IL-2 induces a functionally immature thymic subset to secrete IL-4 and become CTL.

Authors:  K E Stedman; L B Justement; P A Campbell
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

7.  Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit.

Authors:  S Y Lai; J Molden; K D Liu; J M Puck; M D White; M A Goldsmith
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

8.  Interleukin 4 promotes expression of mast cell ICAM-1 antigen.

Authors:  P Valent; D Bevec; D Maurer; J Besemer; F Di Padova; J H Butterfield; W Speiser; O Majdic; K Lechner; P Bettelheim
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

9.  IL-4 acts as a homeostatic regulator of IL-2-induced TNF and IFN-gamma.

Authors:  C Bello-Fernandez; P Oblakowski; A Meager; A S Duncombe; D M Rill; A V Hoffbrand; M K Brenner
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

10.  Interleukin-4 down-regulates adult human astrocyte DNA synthesis and proliferation.

Authors:  M L Estes; K Iwasaki; B S Jacobs; B P Barna
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.